Early research (Phase 1)Ended earlyNCT05135650
What this trial is testing
Pharmacokinetics of Sotrovimab as Pre-exposure Prophylaxis for COVID-19 in Hematopoietic Stem Cell Transplant Recipients, COVIDMAB Study
Who this might be right for
COVID-19 InfectionHematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
Fred Hutchinson Cancer Center 20